Variation Between Multidisciplinary Tumor Boards in Clinical Staging and Treatment Recommendations for Patients With Locally Advanced Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Variation Between Multidisciplinary Tumor Boards in Clinical Staging and Treatment Recommendations for Patients With Locally Advanced Non-small Cell Lung Cancer

Published:2020-12 Issue:6 Volume:158 Page:2675-2687
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Hoeijmakers Fieke,Heineman David J.,Daniels Johannes M.,Beck Naomi,Tollenaar Rob A.E. M.,Wouters Michel W.J. M.,Marang-van de Mheen Perla J.,Schreurs Wilhelmina H.,Barlo Nicole P.,Hoppe Bart P.C.,Jacobs Wouter,Cornelissen Robin,Janssen Joost D.J.,Smulders Sietske A.,Claessens Niels J.M.,van ‘t Westeinde Susan C.,Rutgers Steven R.,Schramel Franz M.N. H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference27 articles.

1. Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers;Lou;Cancer Med,2018

2. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Silvestri;Chest,2013

3. The quality of staging non-small cell lung cancer in the Netherlands: data from the Dutch Lung Surgery Audit;Heineman;Ann Thorac Surg,2016

4. Thoracic multidisciplinary tumor board routinely impacts therapeutic plans in patients with lung and esophageal cancer: a prospective cohort study;Schmidt;Ann Thorac Surg,2015

5. The multidisciplinary lung cancer team meeting: increasing evidence that it should be considered a medical intervention in its own right;Dickhoff;J Thorac Dis,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Strategies: Incorporating Immunotherapy into Stage 3 Non-small Cell Lung Cancer Treatment;Tuberculosis and Respiratory Diseases;2024-07-01

2. The analysis of current international recommendations for the treatment of patients with stage III non-small cell lung cancer;Grekov's Bulletin of Surgery;2024-05-19

3. Multidisciplinary meeting review in nonsmall cell lung cancer: a systematic review and meta-analysis;European Respiratory Review;2024-04-30

4. Challenges and controversies in resectable non-small cell lung cancer: a clinician’s perspective;The Lancet Regional Health - Europe;2024-03

5. Unresectable Stage III NSCLC Can Be Reevaluated for Resectability After Initial Treatment;Journal of Thoracic Oncology;2023-09